Ogata Takatsugu, Narita Yukiya, Misawa Kazunari, Hosoda Waki, Muro Kei
Department of Clinical Oncology Aichi Cancer Center Hospital Aichi Japan.
Department of Surgery Aichi Cancer Center Hospital Aichi Japan.
Clin Case Rep. 2020 Nov 18;9(1):50-56. doi: 10.1002/ccr3.3399. eCollection 2021 Jan.
Although immune checkpoint inhibitors are commonly less effective for patients with a poor general condition, they can be effective and should be considered for poor general conditions in the case of MSI-H tumor.
尽管免疫检查点抑制剂对一般状况较差的患者通常效果较差,但在微卫星高度不稳定(MSI-H)肿瘤的情况下,它们可能有效,对于一般状况较差的患者应予以考虑。